Acute and Long-term Memantine Add-on Treatment to Risperidone Improves Cognitive Dysfunction in Patients with Acute and Chronic Schizophrenia
Discussions Our study gives further evidence that memantine add-on treatment to risperidone may have neuroprotective effects and improve cognitive function in patients with schizophrenia. ClinicalTrials.gov Number: NCT00148590 and NCT00148616. [...] © Georg Thieme Verlag KG Stuttgart · New YorkArticle in Thieme eJournals: Table of contents | Abstract | Full text
Source: Pharmacopsychiatry - Category: Psychiatry Authors: Schaefer, Martin Sarkar, Susanne Theophil, Ines Leopold, Karolina Heinz, Andreas Gallinat, J ürgen Tags: Original Paper Source Type: research
More News: Brain | Learning | Namenda | Neurology | Psychiatry | Risperdal Consta | Schizophrenia | Study | Universities & Medical Training